• 29. 7. 2015

    At his visit to Slovenia Medvedev mentions Krka that has been present in the Russian market for 40 years

    "Russia is willing to cooperate with foreign pharmaceutical companies," said the Prime Minister of Russia Dmytry Medvedev during his three-day visit to Slovenia. On Sunday, 26 July he attended the commemoration ceremony at the Russian Chapel under the Vršič mountain pass. Medvedev was the highest representative of the Russian Federation in the 99 year history of this event. In his interview for Delo daily newspaper he said that Slovene pharmaceutical products in the Russian market are well known and people trust them. As an example Medvedev mentioned Krka. The President of the Management Board and Chief Executive Jože Colarič also attended the ceremony.

  • 19. 6. 2015

    Notica of Resolutions Adopted at the 20th Annual General Meeting of Krka

  • 5. 6. 2015

    Challenge for the experts

    Life challenges us every day and so increases our knowledge and gives us new opportunities. At Krka’s symposium Challenge for the experts, held during the international cardiology meeting Alpe Adria on 3 June in Novo mesto, we put to test the limits of current medical practice in the treatment of cardiovascular diseases.

  • 2. 6. 2015

    Krka receives the 2015 Excellence in Marketing Award

    The Excellence in Marketing Awards were conferred for the first time at the 2015 Slovenian Marketing Conference held in Portorož, Slovenia. Krka won in the category of large B2B companies. Two Slovenian companies BTC d. d. and HALCOM d. d. were among the finalists.

  • 14. 5. 2015

    Krka presented its first quarter 2015 operating results

    The Management Board of Krka, d. d., held a press conference presenting to the public the performance results of the Krka Group and the Krka Company for the first quarter of 2015. The Krka Group sold EUR 289.3 million worth of products and services and generated EUR 55.1 million of profit for the period (up 30%). The Krka Company sold EUR 260.8 million worth of products and generated EUR 49.6 million of profit for the period (up 19%).